Literature DB >> 26184674

Lifestyle modification in the prevention and treatment of atrial fibrillation.

Arthur R Menezes1, Carl J Lavie2, Alban De Schutter1, Richard V Milani1, James O'Keefe3, James J DiNicolantonio3, Daniel P Morin1, Freddy M Abi-Samra1.   

Abstract

Atrial fibrillation (AF) is the most common arrhythmia worldwide and has a significant impact on morbidity and mortality. Additionally, the incidence and prevalence of AF is expected to increase in the United States and worldwide over the next few decades. While the pathophysiology concerning the development of AF is not completely understood, multiple modifiable, as well as non-modifiable risk factors, for AF development have been discovered. The goal of this paper is to provide an overview of the modifiable risk factors that contribute to the development and recurrence of AF, in addition to discussing potential lifestyle changes that may aid in the prevention and treatment of AF.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Diabetes mellitus; Hypertension; Obesity; Obstructive sleep apnea

Mesh:

Year:  2015        PMID: 26184674     DOI: 10.1016/j.pcad.2015.07.001

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  13 in total

Review 1.  The why, when and how to test for obstructive sleep apnea in patients with atrial fibrillation.

Authors:  Lien Desteghe; Jeroen M L Hendriks; R Doug McEvoy; Ching Li Chai-Coetzer; Paul Dendale; Prashanthan Sanders; Hein Heidbuchel; Dominik Linz
Journal:  Clin Res Cardiol       Date:  2018-04-12       Impact factor: 5.460

Review 2.  Management of cardiovascular diseases in patients with obesity.

Authors:  Carl J Lavie; Ross Arena; Martin A Alpert; Richard V Milani; Hector O Ventura
Journal:  Nat Rev Cardiol       Date:  2017-07-27       Impact factor: 32.419

3.  Healthy Lifestyle and Risk of Heart Failure: An Ounce of Prevention Well Worth the Effort.

Authors:  Jerome L Fleg
Journal:  Circ Heart Fail       Date:  2016-04       Impact factor: 8.790

Review 4.  Evaluating the benefits of home-based management of atrial fibrillation: current perspectives.

Authors:  Azfar B Sheikh; Jamie R Felzer; Abdullah Bin Munir; Daniel P Morin; Carl J Lavie
Journal:  Pragmat Obs Res       Date:  2016-10-13

Review 5.  Relation of Body Mass Index With Adverse Outcomes Among Patients With Atrial Fibrillation: A Meta-Analysis and Systematic Review.

Authors:  Wengen Zhu; Rong Wan; Fuwei Liu; Jinzhu Hu; Lin Huang; Juxiang Li; Kui Hong
Journal:  J Am Heart Assoc       Date:  2016-09-09       Impact factor: 5.501

6.  Association between modifiable lifestyle and the prevalence of atrial fibrillation in a Chinese population: Based on the cardiovascular health score.

Authors:  Yiheng Yang; Xu Han; Yue Chen; Lianjun Gao; Xiaomeng Yin; Huihua Li; Jing Qiu; Youxin Wang; Yong Zhou; Yunlong Xia
Journal:  Clin Cardiol       Date:  2017-08-21       Impact factor: 2.882

7.  Sociodemographic, behavioral, and clinical factors associated with low atrial fibrillation knowledge among older adults with atrial fibrillation: The SAGE-AF study.

Authors:  Colleen Sedney; Hawa O Abu; Katherine Trymbulak; Jordy Mehawej; Ziyue Wang; Molly E Waring; Jane Saczynski; David D McManus
Journal:  Patient Educ Couns       Date:  2020-07-15

8.  Are left ventricular ejection fraction and left atrial diameter related to atrial fibrillation recurrence after catheter ablation?: A meta-analysis.

Authors:  Xiao Jin; Jianke Pan; Huanlin Wu; Danping Xu
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

9.  The relationship between the nutritional status and sleep quality of patients with atrial fibrillation.

Authors:  Şeyma Şengül; Hilal Uysal
Journal:  Saudi Med J       Date:  2019-09       Impact factor: 1.484

10.  Combined treatment with valsartan and fluvastatin to delay disease progression in nonpermanent atrial fibrillation with hypertension: A clinical trial.

Authors:  Zhiqiang Zhao; Yu Yang; Jianwei Wang; Zhaojie Dong; Xiaowei Niu; Enzhao Liu; Tong Liu; Lifeng Li; Yingzi Liang; Guangping Li
Journal:  Clin Cardiol       Date:  2020-10-26       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.